Burning Rock Biotech (BNR) Assets (2019 - 2025)

Burning Rock Biotech's Assets history runs 7 years deep, the most recent figure standing at $115.7 million for Q4 2025.

• In Q4 2025, Assets fell 6.15% year-over-year to $115.7 million; the TTM figure through Dec 2025 stood at $115.7 million (down 6.15% YoY), while the FY2025 annual figure was $117.3 million, down 3.28% from the prior year.
• Assets was $115.7 million for Q4 2025 at Burning Rock Biotech, up from $114.1 million in the prior quarter.
• In the past five years, Assets ranged from a high of $409.4 million in Q1 2021 to a low of $114.1 million in Q3 2025.
• Historically, Assets has averaged $215.5 million across 5 years, with a median of $171.7 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Assets dropped 5.53% in 2021, then sank 37.93% in 2023.
• A 5-year view of Assets shows it stood at $356.4 million in 2021, then slumped by 37.37% to $223.2 million in 2022, then tumbled by 35.29% to $144.4 million in 2023, then dropped by 14.67% to $123.2 million in 2024, then slipped by 6.15% to $115.7 million in 2025.
• The last three Assets figures came in at $115.7 million (Q4 2025), $114.1 million (Q3 2025), and $115.2 million (Q2 2025), per Business Quant data.